| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 03/24/2009 | CA2352211C Sustained release matrix systems for highly soluble drugs |
| 03/24/2009 | CA2351203C 2,4-disubstituted triazine derivatives with anti hiv activity |
| 03/24/2009 | CA2338703C Injectable aqueous dispersions of propofol |
| 03/24/2009 | CA2320717C Method for the treatment of diseases or disorders of the inner ear |
| 03/24/2009 | CA2264626C Pharmaceutical composition containing lornoxicam and a disodium salt of edta |
| 03/19/2009 | WO2009036355A1 Transdermal hormone spray |
| 03/19/2009 | WO2009036311A1 Transdermal, alcohol-free, pharmaceutical compositions |
| 03/19/2009 | WO2009036084A2 Adhering troches with topically active ingredients for treatment of throat, esophagus, and stomach |
| 03/19/2009 | WO2009035771A1 Embolization particles |
| 03/19/2009 | WO2009035566A1 Redox-gated liposomes |
| 03/19/2009 | WO2009035562A2 Drug cores for sustained release of therapeutic agents |
| 03/19/2009 | WO2009035496A1 Nutritional dosage unit |
| 03/19/2009 | WO2009035474A1 Abuse resistant drug formulation |
| 03/19/2009 | WO2009035387A1 A medicament prepared using methotrexate and suitable for topical administration, for the treatment of a lower gastrointestinal tract inflammatory disease |
| 03/19/2009 | WO2009035331A1 Hybrid inducible release vehicle |
| 03/19/2009 | WO2009035265A2 Calcium phosphate microspheres drug delivery system and process for preparing the same |
| 03/19/2009 | WO2009035070A1 Transdermally absorbable preparation and transdermally absorbable system using the same |
| 03/19/2009 | WO2009035034A1 Ophthalmic composition |
| 03/19/2009 | WO2009035033A1 Ophthalmic composition |
| 03/19/2009 | WO2009034980A1 Process for producing biological ingesta and biological ingesta obtained thereby |
| 03/19/2009 | WO2009034604A1 Liquid crystal emulsion-type pharmaceutical composition containing cyclosporine, and method of treating cutaneous disease therewith |
| 03/19/2009 | WO2009034541A2 Controlled release pharmaceutical dosage forms of trimetazidine |
| 03/19/2009 | WO2009034540A1 Pharmaceutical composition of sevelamer |
| 03/19/2009 | WO2009034458A2 Oxygen permeable polymeric nanocontainers for encapsulation of sensitive compounds |
| 03/19/2009 | WO2009034431A2 Controlled-release dosage forms for varenicline |
| 03/19/2009 | WO2009034171A1 Pharmaceutical compositions for oral use for treating patients affected by obesity |
| 03/19/2009 | WO2009034148A1 Liposomal formulations for treating cancer |
| 03/19/2009 | WO2009034118A1 Stable formulations of amylin and its analogues |
| 03/19/2009 | WO2009034053A1 Graft copolymers as drug delivery systems |
| 03/19/2009 | WO2009033715A2 Use of slit, nephrin, ephrin or semaphorin for treatment of cartilage diseases |
| 03/19/2009 | WO2009033651A1 Titration package for neramexane and its use in the treatment of an inner ear disorder |
| 03/19/2009 | WO2009033588A2 Self-controlled insulin delivery system |
| 03/19/2009 | WO2009033285A1 Apparatus and method for dehydrating biological materials |
| 03/19/2009 | WO2009033250A1 Composition and method for increasing the anabolic state of muscle cells |
| 03/19/2009 | WO2009023544A3 Dosage unit anion-exchange polymer pharmaceutical compositions |
| 03/19/2009 | WO2009017708A3 Compositions, uses, and method of making wound care products from naturally occurring food ingredients |
| 03/19/2009 | WO2009016069A3 Stable liquid pharmaceutical composition based on trazodone |
| 03/19/2009 | WO2009015890A3 Catalytically active magnetic nanoparticles |
| 03/19/2009 | WO2009015336A3 Controlled release interferon drug products and treatment of hcv infection using same |
| 03/19/2009 | WO2009014372A3 Dispersible tablet comprising coated drug-containing particles and method for the preparation thereof |
| 03/19/2009 | WO2009013261A3 Derivatised polysaccharide material for the topic antibacterial activity |
| 03/19/2009 | WO2009011007A3 Asymmetric liposomes and uses in medical field thereof |
| 03/19/2009 | WO2009007854A3 Oral pouch product including soluble dietary fibers |
| 03/19/2009 | WO2009001144A3 Pharmaceutical aerosol compositions comprising fluticasone |
| 03/19/2009 | WO2008157514A3 Metal ion-treated biocompatible polymers useful for nanoparticles |
| 03/19/2009 | WO2008157335A3 Methods for the treatment of erectile dysfunction using fispemifene |
| 03/19/2009 | WO2008146178A3 A novel tablet dosage form |
| 03/19/2009 | WO2008146018A3 Drug delivery system comprising matrix metalloproteinase inhibitors |
| 03/19/2009 | WO2008132224A3 Method for drying a protein composition, a dried protein composition and a pharmaceutical composition comprising the dried protein |
| 03/19/2009 | WO2008089151A3 High dose film compositions and methods of preparation |
| 03/19/2009 | WO2008082507A3 Pharmaceutical compositions and method for treating inflammation in cattle and other animals |
| 03/19/2009 | WO2008079404A3 Pharmaceutical compositions for treatment of parkinson's disease and related disorders |
| 03/19/2009 | WO2008073731A3 Microemulsion dosage forms of valsartan and methods of making the same |
| 03/19/2009 | WO2008065492A3 A composition for the administration of biologically active principles in gynaecologic and rectal field and uses thereof |
| 03/19/2009 | WO2008065144A3 Galenic formulations of organic compounds |
| 03/19/2009 | WO2007122374A8 Colonic drug delivery formulation |
| 03/19/2009 | WO2006068877A3 Sustained-release nanoparticle compositions and methods for using the same |
| 03/19/2009 | US20090076477 Automatic Liquid Injection System and Method |
| 03/19/2009 | US20090076257 Ester Derivatives of Hyaluronic Acid for the Preparation of Hydrogel Materials by Photocuring |
| 03/19/2009 | US20090076151 Method for stimulating weight loss and/or for lowering triglycerides in patients |
| 03/19/2009 | US20090076123 Medical Compositions for Intravesical Treatment of Bladder Cancer |
| 03/19/2009 | US20090076016 Formulations comprising jorumycin-, renieramycin-, safracin- or saframycin-related compounds for treating proliferative diseases |
| 03/19/2009 | US20090075962 Growth stimulant compositions |
| 03/19/2009 | US20090075961 Testosterone Oral Dosage Formulations And Associated Methods |
| 03/19/2009 | US20090075951 Methods and Reagents for the Treatment of Inflammatory Disorders |
| 03/19/2009 | US20090075950 Dosage Forms Containing A PPI, NSAID And A Buffer |
| 03/19/2009 | US20090075911 Ester Derivatives of Hyaluronic Acid for the Preparation of Hydrogel Materials by Photocuring |
| 03/19/2009 | US20090074944 Enteric coatings for orally ingestible compositions |
| 03/19/2009 | US20090074875 Nanoparticulate compositions having lysozyme as a surface stabilizer |
| 03/19/2009 | US20090074874 Process for Producing Polymer Micelles Encapsulating Low Molecular Weight Drugs |
| 03/19/2009 | US20090074873 Nanoparticulate beclomethasone dipropionate compositions |
| 03/19/2009 | US20090074872 Active Agent Formulations, Methods of Making, and Methods of Use |
| 03/19/2009 | US20090074871 Composition for filling bone defects |
| 03/19/2009 | US20090074870 Alteration of cell membrane for new functions |
| 03/19/2009 | US20090074869 Pharmaceutical formulations |
| 03/19/2009 | US20090074868 Photoinitiated tissue filler |
| 03/19/2009 | US20090074867 Orally dispersible pharmaceutical composition and process for the preparation thereof |
| 03/19/2009 | US20090074866 Dip coated compositions containing copolymer of polyvinyl alcohol and polyethylene glycol and a gum |
| 03/19/2009 | US20090074865 Oral formulations of glycyl-2-methylprolyl-glutamate |
| 03/19/2009 | US20090074864 Novel antimicrobial peptides with heparin binding activity |
| 03/19/2009 | US20090074863 Dosage Forms Containing A PPI, NSAID And A Buffer |
| 03/19/2009 | US20090074862 Low-dose doxepin formulations and methods of making and using the same |
| 03/19/2009 | US20090074861 Stable tablet containing droxidopa |
| 03/19/2009 | US20090074860 Nutritional beverage with skin improvement aids |
| 03/19/2009 | US20090074859 Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
| 03/19/2009 | US20090074858 Sustained-release formulation |
| 03/19/2009 | US20090074857 Glycerophospholipids for the improvement of cognitive functions |
| 03/19/2009 | US20090074856 Crystalline pyrimidine nucleoside derivative suspensions in capsules |
| 03/19/2009 | US20090074855 Enteric coastings for orally ingestible compositions |
| 03/19/2009 | US20090074854 Combined-step process for pharmaceutical compositions |
| 03/19/2009 | US20090074853 Vaccines with enhanced immune response and methods for their preparation |
| 03/19/2009 | US20090074852 Lipoplex formulations for specific delivery to vascular endothelium |
| 03/19/2009 | US20090074851 Cpg-packaged liposomes |
| 03/19/2009 | US20090074850 Use of a topical composition containing epidermal growth factor (egf) for diabetic foot amputation prevention |
| 03/19/2009 | US20090074849 Cancer-suppressing agents |
| 03/19/2009 | US20090074848 Combination formulations of cytidine analogs and platinum agents |
| 03/19/2009 | US20090074847 Transport System In Biological Systems |
| 03/19/2009 | US20090074845 Transdermal active principle delivery means |
| 03/19/2009 | US20090074842 Medicament patch |
| 03/19/2009 | US20090074841 Medicament-based patch |